BioCentury | Aug 23, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2019

...allergic airway diseases Flanders Institute for Biotechnology (VIB); Ghent University Distillery Therapeutics Neurology Parkinson's disease Enterococcus faecalis tyrosine decarboxylase (E. faecalis tyrDC)...
BioCentury | Jul 25, 2019
Distillery Therapeutics

Improving levodopa bioavailability by blocking bacterial metabolism

DISEASE CATEGORY: Neurology INDICATION: Parkinson's disease (PD) A tyrosine analog could improve the bioavailability of PD therapy levodopa by blocking metabolism of levodopa to dopamine by E. faecalis tyrDC. Levodopa crosses the blood-brain barrier where...
Items per page:
1 - 2 of 2